Invesco Ltd.

Position in IVVD — Invivyd, Inc.

CIK 914208 Atlanta, GA

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$396,349

-$98,186 QoQ

Shares Held

454,530

+19.5% QoQ

Ownership

0.154%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 124 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. IVVD ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$396,349	454,530	+19.5%	Shares	Defined	2026-08-14
2026-03-31	$494,535	380,412	+29.6%	Shares	Defined	2026-05-12
2025-12-31	$725,142	293,580	+67.6%	Shares	Defined	2026-02-19
2025-09-30	$192,685	175,169	+28.1%	Shares	Defined	2025-11-13
2025-06-30	$97,779	136,755	+25.5%	Shares	Defined	2025-08-13
2025-03-31	$65,943	108,999	+190.6%	Shares	Defined	2025-05-12
2024-12-31	$16,617	37,514	+9.1%	Shares	Defined	2025-02-13
2024-09-30	$35,076	34,390	-4.2%	Shares	Defined	2024-11-12
2024-06-30	$39,482	35,894	+112.9%	Shares	Defined	2024-08-13
2023-03-31	$20,235	16,863	-6.7%	Shares	Defined	2023-05-12
2022-12-31	$27,100	18,067	+12.9%	Shares	Defined	2023-02-13
2022-09-30	$50,082	16,001	0.0%	Shares	Defined	2022-11-14
2022-06-30	$52,483	16,001	+127.2%	Shares	Defined	2022-08-15
2021-09-30	$297,538	7,044	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.